Update on the use of immunoglobulin in human disease: A review of evidence

[1]  L. Shi,et al.  Intravenous immunoglobulins for epilepsy. , 2019, The Cochrane database of systematic reviews.

[2]  M. Lunn,et al.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. , 2016, The Cochrane database of systematic reviews.

[3]  C. Cunningham-Rundles,et al.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. , 2016, The journal of allergy and clinical immunology. In practice.

[4]  V. Racanelli,et al.  Autoimmune uveitis: clinical, pathogenetic, and therapeutic features , 2016, Clinical and Experimental Medicine.

[5]  R. Damoiseaux,et al.  Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses , 2015, Antimicrobial Agents and Chemotherapy.

[6]  R. Dale,et al.  Immune therapy in autoimmune encephalitis: a systematic review , 2015, Expert review of neurotherapeutics.

[7]  J. Jang,et al.  Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma , 2015, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  S. Kile,et al.  IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  H. Chapel,et al.  Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients , 2015, Clinical and experimental immunology.

[10]  K. Willimann,et al.  Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products , 2015, Transfusion.

[11]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[12]  A. Adler,et al.  Anti-inflammatory treatment for carditis in acute rheumatic fever. , 2015, The Cochrane database of systematic reviews.

[13]  D. Khanna,et al.  Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014 , 2015, Current opinion in rheumatology.

[14]  S. Mineishi,et al.  State-of-the-art acute and chronic GVHD treatment , 2015, International Journal of Hematology.

[15]  I. Bruce,et al.  Indications for IVIG in rheumatic diseases. , 2015, Rheumatology.

[16]  D. Dazzi,et al.  Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. , 2015, The Journal of clinical endocrinology and metabolism.

[17]  S. Ozen,et al.  Vasculitis in children. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Z. Jabbar-Lopez,et al.  Omalizumab, an Anti-IgE mAb, receives approval for the treatment of chronic idiopathic/spontaneous urticaria. , 2015, The Journal of investigative dermatology.

[19]  J. Vierling,et al.  Autoimmune hepatitis , 2015, Frontiers of Medicine.

[20]  M. Seppänen.  Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies , 2014, Clinical and experimental immunology.

[21]  A. Czernik.  Intravenous immunoglobulin G in the treatment of autoimmune bullous disease , 2014, Clinical and experimental immunology.

[22]  V. Bonagura,et al.  Rituximab and immune deficiency: case series and review of the literature. , 2014, The journal of allergy and clinical immunology. In practice.

[23]  W. Sewell,et al.  European consensus proposal for immunoglobulin therapies , 2014, European journal of immunology.

[24]  M. Sanford.  Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders , 2014, BioDrugs.

[25]  Kenneth G. C. Smith,et al.  The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease , 2014, BMC Musculoskeletal Disorders.

[26]  B. Grimbacher,et al.  Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes. , 2014, QJM : monthly journal of the Association of Physicians.

[27]  S. Duraisingham,et al.  Secondary antibody deficiency , 2014, Expert review of clinical immunology.

[28]  F. Rodeghiero,et al.  ITP and international guidelines: what do we know, what do we need? , 2014, Presse medicale.

[29]  F. Cinetto,et al.  Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients , 2014, Haematologica.

[30]  Frank N M Twisk.  The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups , 2014, Front. Physiol..

[31]  Smita Y. Patel,et al.  Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin? , 2014, Journal of Clinical Immunology.

[32]  V. Tesar,et al.  Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters , 2013, Clinical Rheumatology.

[33]  D. Teachey,et al.  Diagnosis and management of autoimmune cytopenias in childhood. , 2013, Pediatric clinics of North America.

[34]  D. Gillis,et al.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin , 2013, Clinical and experimental immunology.

[35]  H. Ihn,et al.  A randomised , double-blind , placebo-controlled trial : intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis , 2013 .

[36]  R. Shapiro,et al.  Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push , 2013, Clinical and experimental immunology.

[37]  N. Kutukculer,et al.  Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy? , 2013, Pediatric reports.

[38]  R. Shapiro.  Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[39]  E. R. Stiehm,et al.  Adverse effects of human immunoglobulin therapy. , 2013, Transfusion medicine reviews.

[40]  Y. Shoenfeld,et al.  Biologic therapy for autoimmune diseases: an update , 2013, BMC Medicine.

[41]  A. Zelenetz,et al.  Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. , 2013, Clinical lymphoma, myeloma & leukemia.

[42]  H. Ochs,et al.  Controversies in IgG replacement therapy in patients with antibody deficiency diseases. , 2013, The Journal of allergy and clinical immunology.

[43]  J. Petrozzino,et al.  Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab , 2013, Transplantation.

[44]  R. Montgomery,et al.  Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA , 2013, Transplantation.

[45]  B. Casanova,et al.  The effect of intravenous immunoglobulin on neuromyelitis optica , 2013 .

[46]  F. Coret,et al.  The effect of intravenous immunoglobulin on neuromyelitis optica. , 2013, Neurologia.

[47]  Katharina Buerger,et al.  Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial , 2013, The Lancet Neurology.

[48]  G. Horneff.  Update on biologicals for treatment of juvenile idiopathic arthritis , 2013, Expert opinion on biological therapy.

[49]  E. Haddad,et al.  Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center. , 2013, The Journal of allergy and clinical immunology.

[50]  R. S. Shapiro.  Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics , 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[51]  J. F. Arevalo,et al.  Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. , 2013, Inflammation & allergy drug targets.

[52]  D. Rigante,et al.  Intravenous immunoglobulin in Henoch-Schönlein purpura complicated by cerebral hemorrhage , 2013, Rheumatology International.

[53]  S. Chevret,et al.  Intravenous immunoglobulin for myasthenia gravis. , 2012, The Cochrane database of systematic reviews.

[54]  V. Bril,et al.  IVIG and PLEX in the treatment of myasthenia gravis , 2012, Annals of the New York Academy of Sciences.

[55]  E. Gelfand.  Intravenous immune globulin in autoimmune and inflammatory diseases. , 2012, The New England journal of medicine.

[56]  T. Fleisher.  Treatment of Neonatal Sepsis With Intravenous Immune Globulin , 2012, Pediatrics.

[57]  J. Puck,et al.  Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. , 2012, The Journal of allergy and clinical immunology.

[58]  A. Cuker,et al.  Contemporary management of primary immune thrombocytopenia in adults , 2012, Journal of thrombosis and haemostasis : JTH.

[59]  C. Watkins,et al.  Intravenous immunoglobulin as a potential therapy for refractory urticaria - a review. , 2012, Inflammation & allergy drug targets.

[60]  D. Wingerchuk.  Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin , 2012, Journal of Clinical Immunology.

[61]  A. Spalice,et al.  Recent Understanding on Diagnosis and Management of Central Nervous System Vasculitis in Children , 2012, Clinical & developmental immunology.

[62]  H. Schroeder,et al.  Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients , 2012, Infection.

[63]  J. Orange,et al.  Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. , 2012, The Journal of allergy and clinical immunology.

[64]  M. Javidan,et al.  Immunomodulation in Adult Epilepsy: The Role of IVIG , 2012, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[65]  B. Ye,et al.  Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients , 2012, Transplantation.

[66]  J. Orange,et al.  Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy , 2012, Clinical and experimental immunology.

[67]  Y.-C. Huang,et al.  The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta‐analysis , 2012, The British journal of dermatology.

[68]  D. Segev,et al.  Infusion of High-Dose Intravenous Immunoglobulin Fails to Lower the Strength of Human Leukocyte Antigen Antibodies in Highly Sensitized Patients , 2012, Transplantation.

[69]  R. Wasserman.  Progress in Gammaglobulin Therapy for Immunodeficiency: From Subcutaneous to Intravenous Infusions and Back Again , 2012, Journal of Clinical Immunology.

[70]  T. Olsson,et al.  Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up , 2012, Journal of Neuroinflammation.

[71]  F. Pellegrini,et al.  Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). , 2012, Blood.

[72]  J. Orange,et al.  Comparison of American and European practices in the management of patients with primary immunodeficiencies , 2012, Clinical and experimental immunology.

[73]  K. Dahan,et al.  Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature. , 2012, Autoimmunity reviews.

[74]  Stefano Tamburin,et al.  Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial , 2012, The Lancet Neurology.

[75]  K. Borg,et al.  IVIG treatment in post-polio patients: evaluation of responders , 2012, Journal of Neurology.

[76]  J. Bussel,et al.  RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME) , 2012, Transfusion.

[77]  T. Hara,et al.  Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial , 2012, The Lancet.

[78]  D. Kuypers.  Management of polyomavirus-associated nephropathy in renal transplant recipients , 2012, Nature Reviews Nephrology.

[79]  D. Pohl,et al.  Treatment of Acute Disseminated Encephalomyelitis , 2012, Current Treatment Options in Neurology.

[80]  C. Bokemeyer,et al.  Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients , 2012, Clinical & developmental immunology.

[81]  D. Campbell,et al.  Intravenous Immunoglobulin to Treat Severe Atopic Dermatitis in Children: A Case Series , 2012, Pediatric dermatology.

[82]  J. Garrity,et al.  The evaluation and treatment of graves ophthalmopathy. , 2012, The Medical clinics of North America.

[83]  F. Bonilla,et al.  The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. , 2012, The Journal of allergy and clinical immunology.

[84]  W. Oertel,et al.  Intravenous Immunoglobulins as a Treatment for Alzheimer’s Disease , 2010, Drugs.

[85]  A N N Gardulf.  Immunoglobulin Treatment for Primary Antibody Deficiencies , 2012, BioDrugs.

[86]  E. Haddad,et al.  Higher Doses of Subcutaneous IgG Reduce Resource Utilization in Patients with Primary Immunodeficiency , 2011, Journal of Clinical Immunology.

[87]  A. Fischer,et al.  Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency , 2011, Front. Immun..

[88]  V. Wahn,et al.  Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy. , 2011, Clinical immunology.

[89]  B. Farrell,et al.  Treatment of neonatal sepsis with intravenous immune globulin. , 2011, The New England journal of medicine.

[90]  Y. Rajabally,et al.  Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year study , 2011, Journal of the Neurological Sciences.

[91]  A. Koterba,et al.  Safety and efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases , 2011, Postgraduate medicine.

[92]  H. Gürcan,et al.  Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[93]  F. Cambazard,et al.  Solar urticaria treated with intravenous immunoglobulins. , 2011, Journal of the American Academy of Dermatology.

[94]  B. Tatlı,et al.  Acute disseminated encephalomyelitis (ADEM) after pertussis infection , 2011, Annals of tropical paediatrics.

[95]  Y. Hong,et al.  Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease , 2011, Korean circulation journal.

[96]  E. Wood,et al.  Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications , 2011, Annals of Hematology.

[97]  B. Grimbacher,et al.  Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency , 2011, Journal of Clinical Immunology.

[98]  M. Berger.  Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD , 2011, Journal of Clinical Immunology.

[99]  R. Nelson,et al.  Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency , 2011, Clinical pharmacokinetics.

[100]  D. Cocito,et al.  The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin , 2011, Journal of the peripheral nervous system : JPNS.

[101]  H. Ochs,et al.  Efficacy and safety of home‐based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies , 2011, Clinical and experimental immunology.

[102]  J. Ongrádi,et al.  Numerical alterations of ageing B lymphocyte subsets. , 2011, Acta physiologica Hungarica.

[103]  J. Bussel,et al.  Antenatal interventions for fetomaternal alloimmune thrombocytopenia. , 2011, The Cochrane database of systematic reviews.

[104]  V. Bril,et al.  Comparison of IVIg and PLEX in patients with myasthenia gravis , 2011, Neurology.

[105]  M. Rojavin,et al.  Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. , 2011, Clinical immunology.

[106]  F. Bonilla.  IgG replacement therapy, no size fits all. , 2011, Clinical immunology.

[107]  M. Crowther,et al.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. , 2011, Blood.

[108]  W. Sewell,et al.  Serum trough IgG level and annual intravenous immunoglobulin dose are not related to body size in patients on regular replacement therapy. , 2011, Drug metabolism letters.

[109]  A. Plebani,et al.  Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study , 2011, Journal of Clinical Immunology.

[110]  B. Ata,et al.  A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. , 2011, Fertility and sterility.

[111]  I. Elovaara,et al.  Intravenous Immunoglobulins Are a Therapeutic Option in the Treatment of Multiple Sclerosis Relapse , 2011, Clinical neuropharmacology.

[112]  B. Jacobs,et al.  Emerging drugs for Guillain-Barré syndrome , 2011, Expert opinion on emerging drugs.

[113]  Jae-Won Oh,et al.  Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis , 2011, Allergy, asthma & immunology research.

[114]  A. Vo,et al.  Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[115]  C. Cunningham-Rundles,et al.  Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion. , 2010, The Journal of allergy and clinical immunology.

[116]  Steven M. Holland,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2009, Front. Immun..

[117]  J. Stockman.  Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006 , 2011 .

[118]  A. Gabrielli,et al.  Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. , 2011, Autoimmunity reviews.

[119]  M. Keating,et al.  leukemia Advances in the biology and treatment of B-cell chronic lymphocytic , 2011 .

[120]  B. Blomberg,et al.  Aging Affects Human B Cell Responses , 2011, Journal of Clinical Immunology.

[121]  M. Chiarini,et al.  The Different Extent of B and T Cell Immune Reconstitution after Hematopoietic Stem Cell Transplantation and Enzyme Replacement Therapies in SCID Patients with Adenosine Deaminase Deficiency , 2010, The Journal of Immunology.

[122]  P. Bergh,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.

[123]  J. Orange,et al.  Therapeutic Use of Immunoglobulins , 2010, Advances in Pediatrics.

[124]  J. Jakobsen,et al.  Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy , 2010, Neurology.

[125]  J. Orange,et al.  Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. , 2010, Clinical immunology.

[126]  U. Maggiore,et al.  Increased viral load after intravenous immunoglobulin therapy for BK virus‐associated nephropathy , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[127]  R. Keren,et al.  Corticosteroids May Improve Clinical Outcomes During Hospitalization for Henoch-Schönlein Purpura , 2010, Pediatrics.

[128]  G. Bergman,et al.  Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G , 2010, Southern medical journal.

[129]  S. Gupta,et al.  Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease , 2010, Clinical and experimental immunology.

[130]  Christopher W. Calabria,et al.  Multiple treatment cycles of high-dose intravenous immunoglobulin for chronic spontaneous urticaria. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[131]  G. Patterson,et al.  Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[132]  C. Cunningham-Rundles.  How I treat common variable immune deficiency. , 2010, Blood.

[133]  H. Hartung,et al.  Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. , 2010, Archives of neurology.

[134]  B. Grimbacher,et al.  Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency , 2010, European journal of medical research.

[135]  M. Rosenfeld,et al.  Update on Paraneoplastic and Autoimmune Disorders of the Central Nervous System , 2010, Seminars in neurology.

[136]  G. Comi,et al.  Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report , 2010, Neurological Sciences.

[137]  R. Goeree,et al.  Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada , 2010, Cost effectiveness and resource allocation : C/E.

[138]  E. Thervet,et al.  Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study , 2010, Transplantation.

[139]  H. Osaka,et al.  Nationwide survey (incidence, clinical course, prognosis) of Rasmussen’s encephalitis , 2010, Brain and Development.

[140]  E. López-Granados,et al.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. , 2010, The Journal of allergy and clinical immunology.

[141]  S. Turbeville,et al.  Current therapy for Lambert–Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment , 2010, Current medical research and opinion.

[142]  S. Jordan,et al.  Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation , 2010, Transplantation.

[143]  Kathleen C. Williams,et al.  Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. , 2010, Clinical immunology.

[144]  A. Goebel.  Immunoglobulin Responsive Chronic Pain , 2010, Journal of Clinical Immunology.

[145]  T. Hannan,et al.  Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation or Treated with Immunomodulatory Agents. , 2010, Mediterranean journal of hematology and infectious diseases.

[146]  B. Jacobs,et al.  IVIG Treatment and Prognosis in Guillain–Barré Syndrome , 2010, Journal of Clinical Immunology.

[147]  É. Oksenhendler,et al.  Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels , 2010, Journal of Clinical Immunology.

[148]  Sudhir Gupta,et al.  Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin , 2010, Journal of Clinical Immunology.

[149]  A. Vincent,et al.  Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems , 2010, Journal of Clinical Immunology.

[150]  R. Buckley.  B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. , 2010, The Journal of allergy and clinical immunology.

[151]  Y. Rajabally,et al.  Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins , 2010, Biologics : targets & therapy.

[152]  M. Nahm,et al.  The effect of age on the response to the pneumococcal polysaccharide vaccine , 2010, BMC infectious diseases.

[153]  M. Pasnoor,et al.  Clinical findings in MuSK‐antibody positive myasthenia gravis: A U.S. experience , 2010, Muscle & nerve.

[154]  M. Bechtel,et al.  Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature. , 2010, Journal of drugs in dermatology : JDD.

[155]  P. Staubach,et al.  Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[156]  S. Gupta,et al.  Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy , 2010, Clinical and experimental immunology.

[157]  S. Heymans,et al.  Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load , 2010, Antiviral therapy.

[158]  S. Spector,et al.  Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency , 2010, Journal of Clinical Immunology.

[159]  N. Hammel,et al.  Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy. , 2010, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[160]  Drew Provan,et al.  International consensus report on the investigation and management of primary immune thrombocytopenia. , 2010, Blood.

[161]  M. Duse,et al.  Transient Hypogammaglobulinemia of Infancy: Intravenous Immunoglobulin as First Line Therapy , 2010, International journal of immunopathology and pharmacology.

[162]  J. Heath,et al.  Idiopathic Thrombocytopenic Purpura in a Boy With Ataxia Telangiectasia on Immunoglobulin Replacement Therapy , 2010, Journal of pediatric hematology/oncology.

[163]  A. Fischer,et al.  Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies , 2009, Clinical and experimental immunology.

[164]  S. Kaveri,et al.  Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin , 2009, Autoimmunity Reviews.

[165]  N. Gilhus,et al.  Guidelines for treatment of autoimmune neuromuscular transmission disorders , 2006, European journal of neurology.

[166]  E. Haddad,et al.  The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. , 2010, Transfusion medicine reviews.

[167]  V. Sánchez.  Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation , 2010 .

[168]  H. Gürcan,et al.  Intravenous Immunoglobulin Therapy in Autoimmune Mucocutaneous Blistering Diseases , 2010, American Journal of Clinical Dermatology.

[169]  B. Jaar,et al.  Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature. , 2010, Journal of hospital medicine.

[170]  S. Nahirniak,et al.  Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation. , 2010, Transfusion medicine reviews.

[171]  A. Ohlsson,et al.  Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. , 2010, The Cochrane database of systematic reviews.

[172]  R. Shapiro.  Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis , 2010, Journal of Clinical Immunology.

[173]  S. Jordan,et al.  Advances in diagnosing and managing antibody-mediated rejection , 2010, Pediatric Nephrology.

[174]  J. Ongrádi,et al.  Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment. , 2009, Acta microbiologica et immunologica Hungarica.

[175]  G. Murphy,et al.  Solar urticaria successfully treated with intravenous immunoglobulin , 2009, Clinical and experimental dermatology.

[176]  H. Ochs,et al.  Subcutaneous immunoglobulin: opportunities and outlook , 2009, Clinical and experimental immunology.

[177]  R. Hughes,et al.  Clinical applications of intravenous immunoglobulins in neurology , 2009, Clinical and experimental immunology.

[178]  Boris Katz,et al.  The 2009 COID Recommendations for RSV Prophylaxis: Issues of Efficacy, Cost, and Evidence-Based Medicine , 2009, Pediatrics.

[179]  S. Jordan,et al.  Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[180]  James E. Levin,et al.  Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[181]  M. Bromberg,et al.  Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the aanem AD HOC committee , 2009, Muscle & nerve.

[182]  N. Relkin,et al.  18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease , 2009, Neurobiology of Aging.

[183]  H. Hartung,et al.  Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology , 2009, Clinical and experimental immunology.

[184]  M. Berger,et al.  A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously. , 2009, The Journal of allergy and clinical immunology.

[185]  Jinhua Xu,et al.  Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens–Johnson syndrome: a retrospective comparative study in China , 2009, International journal of dermatology.

[186]  E. Davies,et al.  Update on the management of the immunodeficiency in ataxia-telangiectasia , 2009, Expert review of clinical immunology.

[187]  C. Catsman-Berrevoets,et al.  Landau‐Kleffner syndrome and CSWS syndrome: Treatment with intravenous immunoglobulins , 2009, Epilepsia.

[188]  S. Jordan,et al.  Intravenous immunoglobulin a natural regulator of immunity and inflammation. , 2009, Transplantation.

[189]  A. Thrasher,et al.  Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin , 2009, British journal of haematology.

[190]  K. Gauvreau,et al.  Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006 , 2009, Pediatrics.

[191]  O. Khan,et al.  INTRAVENOUS IMMUNOGLOBULIN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A DOSE-FINDING TRIAL , 2009, Neurology.

[192]  L. H. van den Berg,et al.  Subcutaneous immunoglobulin therapy for multifocal motor neuropathy , 2009, Journal of the peripheral nervous system : JPNS.

[193]  C. Cunningham-Rundles,et al.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions , 2009, British journal of haematology.

[194]  Tomio Kobayashi,et al.  Risk Stratification in the Decision to Include Prednisolone With Intravenous Immunoglobulin in Primary Therapy of Kawasaki Disease , 2009, The Pediatric infectious disease journal.

[195]  J. Jakobsen,et al.  Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trial , 2009, European journal of neurology.

[196]  D. Nochy,et al.  Comparison of Combination Plasmapheresis/IVIg/Anti‐CD20 Versus High‐Dose IVIg in the Treatment of Antibody‐Mediated Rejection , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[197]  H. Shimizu,et al.  A randomized double-blind trial of intravenous immunoglobulin for pemphigus. , 2009, Journal of the American Academy of Dermatology.

[198]  C. Kessler,et al.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A , 2009, Haematologica.

[199]  E. Makrakis,et al.  Low‐molecular‐weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[200]  A. Razzaque Ahmed,et al.  Treatment of Juvenile Pemphigus Vulgaris with Intravenous Immunoglobulin Therapy , 2009, Pediatric dermatology.

[201]  J. Callen,et al.  Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands. , 2009, Archives of dermatology.

[202]  M. Narra,et al.  Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults , 2009, International Archives of Allergy and Immunology.

[203]  F. Rehman,et al.  Intravenous immunoglobulin as rescue therapy for BK virus nephropathy , 2009, Pediatric transplantation.

[204]  L. Leibovici,et al.  Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis , 2009, Leukemia & lymphoma.

[205]  R. Hughes.  Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial , 2009, Expert review of neurotherapeutics.

[206]  A. Enk.  Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. , 2009, European journal of dermatology : EJD.

[207]  Michael W. Jackson,et al.  An Autoantibody in Narcolepsy Disrupts Colonic Migrating Motor Complexes , 2008, The Journal of Neuroscience.

[208]  H. Chapel,et al.  Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita. , 2008, Clinical immunology.

[209]  F. Bonilla.  Intravenous immunoglobulin: adverse reactions and management. , 2008, The Journal of allergy and clinical immunology.

[210]  H. Chapel,et al.  Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy. , 2008, Immunology and allergy clinics of North America.

[211]  M. Berger.  Subcutaneous administration of IgG. , 2008, Immunology and allergy clinics of North America.

[212]  E. Stiehm,et al.  Genetic syndromic immunodeficiencies with antibody defects. , 2008, Immunology and allergy clinics of North America.

[213]  K. Cimon,et al.  Economic assessment of different modalities of immunoglobulin replacement therapy. , 2008, Immunology and allergy clinics of North America.

[214]  T. Chatila,et al.  Immunoglobulin replacement therapy in children. , 2008, Immunology and allergy clinics of North America.

[215]  M. Eibl.  History of immunoglobulin replacement. , 2008, Immunology and allergy clinics of North America.

[216]  F. Bonilla.  Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes. , 2008, Immunology and allergy clinics of North America.

[217]  A. Rubinstein,et al.  Intravenous gammaglobulin treatment in HIV-1 infection. , 2008, Immunology and allergy clinics of North America.

[218]  C. Baumann,et al.  No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy , 2008, Journal of Neurology.

[219]  L. Myer,et al.  The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: A retrospective cohort study , 2008, BMC infectious diseases.

[220]  E. Mignot,et al.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy , 2008, Journal of Neurology.

[221]  R. Perricone,et al.  Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. , 2008, Rheumatology.

[222]  N. Gilhus,et al.  EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases , 2008, European journal of neurology.

[223]  Y. Aoyama,et al.  Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG. , 2008, European journal of dermatology : EJD.

[224]  M. Dalakas.  IVIg in other autoimmune neurological disorders: current status and future prospects , 2008, Journal of Neurology.

[225]  R. Hughes.  The role of IVIg in autoimmune neuropathies: the latest evidence , 2008, Journal of Neurology.

[226]  J. Quinn,et al.  Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[227]  V. Bonagura,et al.  Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. , 2008, The Journal of allergy and clinical immunology.

[228]  W. Sheremata,et al.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Multiple Sclerosis , 2008, Journal of clinical neuromuscular disease.

[229]  M. Gönül,et al.  Intravenous immunoglobulin therapy in dermatologic disorders. , 2008, Inflammation & allergy drug targets.

[230]  D. Figarella-Branger,et al.  Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis? , 2008, Clinical Rheumatology.

[231]  L. Hammarström,et al.  Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies , 2008, Clinical and experimental immunology.

[232]  J. Bystryn,et al.  Kinetics of response to conventional treatment in patients with pemphigus vulgaris. , 2008, Archives of dermatology.

[233]  S. Sathasivam.  Brown-Vialetto-Van Laere syndrome , 2008, Orphanet journal of rare diseases.

[234]  A. Exley,et al.  Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. , 2008, Clinical immunology.

[235]  E. Winger,et al.  Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. , 2008, American journal of reproductive immunology.

[236]  K. Gibson,et al.  Corticosteroid Therapy for Henoch Schönlein Purpura , 2008, Pediatrics.

[237]  W. Paulus,et al.  Subcutaneous immunoglobulin infusion: A new therapeutic option in chronic inflammatory demyelinating polyneuropathy , 2008, Muscle & nerve.

[238]  A. Fasth,et al.  Quality of Life and Health-Care Resource Utilization Among Children with Primary Immunodeficiency Receiving Home Treatment with Subcutaneous Human Immunoglobulin , 2008, Journal of Clinical Immunology.

[239]  H. Hartung,et al.  Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial , 2008, The Lancet Neurology.

[240]  R. Holman,et al.  Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in Japan , 2008, The Pediatric infectious disease journal.

[241]  R. Nelson,et al.  Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies , 2008, Journal of Clinical Immunology.

[242]  A. Plebani,et al.  Prospective Study on CVID Patients with Adverse Reactions to Intravenous or Subcutaneous IgG Administration , 2008, Journal of Clinical Immunology.

[243]  T. Maisonobe,et al.  Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[244]  E. Bunnik,et al.  Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals. , 2007, AIDS research and human retroviruses.

[245]  O. Ishikawa,et al.  Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy. , 2007, Journal of the American Academy of Dermatology.

[246]  D. Stephens,et al.  Randomized controlled trial of short‐term withdrawal of i.v. immunoglobulin therapy for selected children with human immunodeficiency virus infection , 2007, Pediatrics international : official journal of the Japan Pediatric Society.

[247]  A. Fasth,et al.  Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency , 2007, Acta paediatrica.

[248]  D. Annane,et al.  Immunotherapy for Guillain-Barré syndrome: a systematic review. , 2007, Brain : a journal of neurology.

[249]  E. Faria,et al.  Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. , 2007, European annals of allergy and clinical immunology.

[250]  L. Lagae,et al.  Intravenous Immunoglobulins in Refractory Childhood‐Onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile , 2007, Epilepsia.

[251]  B. Leber,et al.  Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura , 2007, Vox sanguinis.

[252]  M. Ballow.  Safety of IGIV therapy and infusion-related adverse events , 2007, Immunologic research.

[253]  M. Jinnin,et al.  High‐dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma , 2007, The British journal of dermatology.

[254]  Koji Yamamoto,et al.  Intravenous Immunoglobulin Therapy for Acquired Coagulation Inhibitors: A Critical Review , 2007, International journal of hematology.

[255]  H. Przuntek,et al.  Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study , 2007, Multiple sclerosis.

[256]  V. Blanchette,et al.  Guidelines on the use of intravenous immune globulin for hematologic conditions. , 2007, Transfusion medicine reviews.

[257]  T. Feasby,et al.  Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions. , 2007, Transfusion medicine reviews.

[258]  J. Freedman,et al.  Guidelines on the use of intravenous immune globulin for neurologic conditions. , 2007, Transfusion medicine reviews.

[259]  R. Branch,et al.  Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. , 2007, American journal of infection control.

[260]  E. Jerschow,et al.  A case of common variable immunodeficiency syndrome associated with Takayasu arteritis. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[261]  B. Hutton,et al.  Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review , 2007, BJOG : an international journal of obstetrics and gynaecology.

[262]  K. Warnatz,et al.  Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. , 2007, Clinical immunology.

[263]  P. Forsberg,et al.  Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: A long-term follow-up , 2007, Scandinavian journal of infectious diseases.

[264]  A N N Gardulf.  Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route. , 2007, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[265]  N. Gueven,et al.  Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. , 2007, British medical bulletin.

[266]  M. Thomson,et al.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion , 2007, European Journal of Pediatrics.

[267]  S. Kato,et al.  Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis , 2007, Heart and Vessels.

[268]  J. Orange,et al.  Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[269]  P. Lepper,et al.  High‐dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long‐term follow‐up , 2006, Clinical and experimental immunology.

[270]  N. Shear,et al.  Canadian Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in Dermatology , 2006, Journal of cutaneous medicine and surgery.

[271]  U. Zettl,et al.  Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis , 2006, Journal of Neurology.

[272]  M. Dalakas.  Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects , 2006, Journal of Neurology.

[273]  H. Hartung,et al.  Subcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathies , 2006, Journal of Neurology.

[274]  T. Matsuishi,et al.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.

[275]  S. Kurotobi,et al.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment , 2006, European Journal of Pediatrics.

[276]  C. Cunningham-Rundles,et al.  X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.

[277]  Y. Dauvilliers.  Follow‐up of four narcolepsy patients treated with intravenous immunoglobulins , 2006, Annals of neurology.

[278]  S. Jordan,et al.  Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[279]  B. Grimbacher,et al.  Patients' Attitude to Subcutaneous Immunoglobulin Substitution as Home Therapy , 2006, Journal of Clinical Immunology.

[280]  S. Phuphanich,et al.  Neurologic Improvement after High-dose Intravenous Immunoglobulin Therapy in Patients with Paraneoplastic Cerebellar Degeneration Associated with Anti-Purkinje Cell Antibody , 2006, Journal of Neuro-Oncology.

[281]  Tomio Kobayashi,et al.  Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.

[282]  H. Ochs,et al.  Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases , 2006, Journal of Clinical Immunology.

[283]  J. Church,et al.  Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency , 2006, Journal of Clinical Immunology.

[284]  M. van der Burg,et al.  An antibody-deficiency syndrome due to mutations in the CD19 gene. , 2006, The New England journal of medicine.

[285]  J. Kirmse.  Subcutaneous Administrationof Immunoglobulin , 2006, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[286]  Ó. Asensio,et al.  Rapid Subcutaneous IgG Replacement Therapy is Effective and Safe in Children and Adults with Primary Immunodeficiencies—A Prospective, Multi-National Study , 2006, Journal of Clinical Immunology.

[287]  J. Orange,et al.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. , 2006, The Journal of allergy and clinical immunology.

[288]  C. Rees,et al.  Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea , 2006, Diseases of the colon and rectum.

[289]  H. Ihn,et al.  High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: report on one case and review of the literature. , 2006, Clinical rheumatology.

[290]  Y. Shoenfeld,et al.  Intravenous immunoglobulin and recurrent pregnancy loss , 2005, Clinical reviews in allergy & immunology.

[291]  J. Siegel.  The Product: All Intravenous Immunoglobulins Are Not Equivalent , 2005, Pharmacotherapy.

[292]  M. Jinnin,et al.  A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion. , 2005, Rheumatology.

[293]  M. Dalakas.  The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies , 2005, Journal of Neurology.

[294]  J. Craig,et al.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. , 2005, The Cochrane database of systematic reviews.

[295]  L. H. van den Berg,et al.  Intravenous immunoglobulin for multifocal motor neuropathy. , 2005, The Cochrane database of systematic reviews.

[296]  E. Stiehm,et al.  Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin. , 2005, The Pediatric infectious disease journal.

[297]  S. Swedo,et al.  Annotation: PANDAS: a model for human autoimmune disease. , 2005, Journal of child psychology and psychiatry, and allied disciplines.

[298]  M. Nelson,et al.  Autoimmune urticaria response to high-dose intravenous immunoglobulin. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[299]  D. Kerrin,et al.  Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic , 2005, Pediatric pulmonology.

[300]  D. Redelmeier,et al.  Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency , 1996, Inflammation.

[301]  S. Jordan.  Treatment of systemic and renal-limited vasculitic disorders with pooled human intravenous immune globulin , 1995, Journal of Clinical Immunology.

[302]  Y. Shoenfeld,et al.  Autoimmune multiorgan involvement in elderly men is it SLE? , 1994, Clinical Rheumatology.

[303]  B. Engelen,et al.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study , 1994, European Journal of Pediatrics.

[304]  G. Mitropoulou,et al.  Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin , 1989, Klinische Wochenschrift.

[305]  J. Newsom-Davis,et al.  Treatment for Lambert-Eaton myasthenic syndrome. , 2005, The Cochrane database of systematic reviews.

[306]  J. Touchon,et al.  Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset , 2004, Annals of neurology.

[307]  D. Stablein,et al.  Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. , 2004, Journal of the American Society of Nephrology : JASN.

[308]  A. Plebani,et al.  Corrigendum to “Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency” [Clin. Immunol. 110 (2004) 22–29] , 2004 .

[309]  Ó. Asensio,et al.  Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. , 2004, The Journal of allergy and clinical immunology.

[310]  A. Achiron,et al.  Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. , 2004, Archives of neurology.

[311]  H. Möller,et al.  Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[312]  A. Achiron,et al.  Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis , 2004, Journal of Neurology.

[313]  M. Jaloudi,et al.  Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature , 2004, Annals of Hematology.

[314]  F. Bonilla.  PROSPECTIVE AUDIT OF ADVERSE REACTIONS OCCURRING IN 459 PRIMARY ANTIBODY-DEFICIENT PATIENTS RECEIVING INTRAVENOUS IMMUNOGLOBULIN , 2004, Pediatrics.

[315]  M. Berger.  Subcutaneous immunoglobulin replacement in primary immunodeficiencies. , 2004, Clinical immunology.

[316]  S. Amadori,et al.  Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. , 2004, Blood.

[317]  M. Dalakas,et al.  The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. , 2004, Pharmacology & therapeutics.

[318]  E. Pallisa,et al.  Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. , 2004, International immunopharmacology.

[319]  J. Furui,et al.  Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. , 2004, Jornal de Pediatria.

[320]  J. Leonard,et al.  The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura , 2004, British journal of haematology.

[321]  J. Sinclair,et al.  Increased risk of adverse events when changing intravenous immunoglobulin preparations , 2004, Clinical and experimental immunology.

[322]  Y. Shoenfeld,et al.  Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. , 2004, Arthritis and rheumatism.

[323]  J. Meulstee,et al.  Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial , 2004, The Lancet.

[324]  P. Visintainer,et al.  Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura , 2004, Pediatric blood & cancer.

[325]  A. Osterhaus,et al.  Vaccination with Rabies to Study the Humoral and Cellular Immune Response to a T-Cell Dependent Neoantigen in Man , 2003, Journal of Clinical Immunology.

[326]  A N N Gardulf,et al.  Rapid Subcutaneous IgG Replacement Therapy at Home for Pregnant Immunodeficient Women , 2001, Journal of Clinical Immunology.

[327]  D. Ericson,et al.  The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy , 2000, Journal of Clinical Immunology.

[328]  E. Moxon,et al.  Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review , 1992, Journal of Clinical Immunology.

[329]  C. Mueller-Eckhardt,et al.  High-dose IgG for post-transfusion purpura-revisited , 1988, Blut.

[330]  R. Schiff,et al.  Alterations in the half-life and clearance of IgG during therapy with intravenous γ-globulin in 16 patients with severe primary humoral immunodeficiency , 1986, Journal of Clinical Immunology.

[331]  A. Gianella-Borradori,et al.  Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin , 1984, Blut.

[332]  M. Welch,et al.  Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin , 1983, Journal of Clinical Immunology.

[333]  R. Buckley.  Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem , 1982, Journal of Clinical Immunology.

[334]  L. Mortier,et al.  Urticaire solaire traitée par l’association immunoglobulines polyvalentes et PUVAthérapie , 2004 .

[335]  A. Ohlsson,et al.  Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. , 2004, The Cochrane database of systematic reviews.

[336]  L. Mortier,et al.  [Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy]. , 2004, Annales de dermatologie et de venereologie.

[337]  M. Sato,et al.  IgG Anti-IgA Subclasses in Common Variable Immunodeficiency and Association with Severe Adverse Reactions to Intravenous Immunoglobulin Therapy , 2004, Journal of Clinical Immunology.

[338]  C. Cunningham-Rundles,et al.  Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies , 2004, Journal of Clinical Immunology.

[339]  J. Casanova,et al.  An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. , 2003, Clinical immunology.

[340]  R. Geha,et al.  The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients , 2003, Medicine.

[341]  L. Haines,et al.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children. , 2003, The Cochrane database of systematic reviews.

[342]  G. Dawn,et al.  Effect of high‐dose intravenous immunoglobulin in delayed pressure urticaria , 2003, The British journal of dermatology.

[343]  Z. Ballas,et al.  Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients. , 2003, The Journal of allergy and clinical immunology.

[344]  Y. Sakakihara,et al.  High‐dose immunoglobulin therapy for Guillain−Barré syndrome in Japanese children , 2003, Pediatrics international : official journal of the Japan Pediatric Society.

[345]  T. Granata.  Rasmussen’s syndrome , 2003, Neurological Sciences.

[346]  P. Sørensen.  Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials , 2003, Neurological Sciences.

[347]  M. Eibl.  Intravenous immunoglobulins in neurological disorders: safety issues , 2003, Neurological Sciences.

[348]  P. Korenblat,et al.  Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. , 2003, International immunopharmacology.

[349]  A. Ahmed,et al.  Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. , 2003, Archives of dermatology.

[350]  R. O’Hehir,et al.  Role of intravenous immunoglobulin in severe steroid‐dependent asthma , 2003, Internal medicine journal.

[351]  A. Tristano,et al.  Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. , 2003, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[352]  H. Hsu,et al.  Intravenous immunoglobulin in the preparation of thymectomy for myasthenia gravis , 2003, Acta neurologica Scandinavica.

[353]  R. Forbes,et al.  Intravenous immunoglobulins for multiple sclerosis. , 2003, The Cochrane database of systematic reviews.

[354]  H. Kroll,et al.  European collaborative study of the antenatal management of feto‐maternal alloimmune thrombocytopenia , 2003, British journal of haematology.

[355]  S. Chevret,et al.  Should Immunoglobulin Therapy Be Used in Allogeneic Stem-Cell Transplantation? , 2003, Annals of Internal Medicine.

[356]  I. Bruce,et al.  Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[357]  J. Freedman,et al.  Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. , 2003, Blood.

[358]  P. Bordigoni,et al.  Successful treatment of chronic parvovirus B19 infection by high-dose immunoglobulin. , 2003, Clinical nephrology.

[359]  A. Ropper.  Current treatments for CIDP , 2003, Neurology.

[360]  E. Shahar,et al.  Outcome of Severe Guillain–Barré Syndrome in Children: Comparison Between Untreated Cases Versus Gamma-Globulin Therapy , 2003, Clinical neuropharmacology.

[361]  J. Henter,et al.  Randomized Study of IVIg and High-Dose Dexamethasone Therapy for Children With Chronic Idiopathic Thrombocytopenic Purpura , 2003, Journal of pediatric hematology/oncology.

[362]  R. Nelson,et al.  26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies. , 2003, The Journal of allergy and clinical immunology.

[363]  M. Jackson,et al.  Streptococcal Fasciitis With Toxic Shock Syndrome in the Pediatric Patient , 2003, Orthopedic nursing.

[364]  M. Pless,et al.  Subacute rhombencephalitis optica responsive to intravenous immunoglobulins , 2003, European journal of neurology.

[365]  S. Chevret,et al.  Intravenous immunoglobulin for myasthenia gravis. , 2003, The Cochrane database of systematic reviews.

[366]  P. Korenblat,et al.  A randomized double-blind trial , 2003 .

[367]  S. Jolles,et al.  Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. , 2003, Acta dermato-venereologica.

[368]  M. Vermeulen,et al.  Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review , 2002, The Lancet Neurology.

[369]  R. Sundel.  Update on the treatment of kawasaki disease in childhood , 2002, Current rheumatology reports.

[370]  M. Kothari,et al.  Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome , 2002, The Journal of the American Osteopathic Association.

[371]  E. Bosmans,et al.  Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism , 2002, Psychological Medicine.

[372]  F. Fazekas,et al.  Intravenous immunoglobulin G for the treatment of relapsing–remitting multiple sclerosis: a meta‐analysis , 2002, European journal of neurology.

[373]  D. Kumararatne,et al.  Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. , 2002, QJM : monthly journal of the Association of Physicians.

[374]  C. Cunningham-Rundles,et al.  Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency. , 2002, The Journal of allergy and clinical immunology.

[375]  G. Parry,et al.  Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis , 2002, Muscle & nerve.

[376]  S. Chevret,et al.  A randomized controlled evaluator‐blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis , 2002, The British journal of dermatology.

[377]  E. Anyanwu,et al.  Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A , 2002, Journal of Neuroimmunology.

[378]  A. Ziman,et al.  A second case of post‐transfusion purpura caused by HPA‐5a antibodies: successful treatment with intravenous immunoglobulin , 2002, Vox sanguinis.

[379]  H. Möller,et al.  Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease , 2002 .

[380]  L. H. van den Berg,et al.  Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. , 2002, Brain : a journal of neurology.

[381]  J. Vierling,et al.  Evolving new therapies of autoimmune hepatitis. , 2002, Clinics in liver disease.

[382]  H. Liley,et al.  Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. , 2002, The Cochrane database of systematic reviews.

[383]  H. Çaksen,et al.  Atypical benign partial epilepsy of childhood (pseudo-Lennox syndrome): report of two brothers. , 2002, Neurology India.

[384]  C. Cunningham-Rundles,et al.  Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. , 2002, The Journal of allergy and clinical immunology.

[385]  J. EspinosaZacarías,et al.  Tratamiento intravenoso con inmunoglobulinas en síndromes epilépticos de difícil control , 2002 .

[386]  T. Luger,et al.  Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases. , 2002, Current opinion in investigational drugs.

[387]  B. McCrindle,et al.  Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. , 2002 .

[388]  H. Tsuda,et al.  The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[389]  M. Tarantino.  Acute immune (idiopathic) thrombocytopenic purpura in childhood. , 2002, Blood reviews.

[390]  O. Christiansen,et al.  A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. , 2002, Human reproduction.

[391]  H. Lazarus,et al.  Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[392]  F. Massari,et al.  High‐dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature , 2002, Journal of internal medicine.

[393]  S. Chevret,et al.  Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial , 2002, The Lancet.

[394]  N. Yaralı,et al.  CLINICAL COURSE OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA TREATED WITH INTRAVENOUS IMMUNOGLOBULIN G OR MEGADOSE METHYLPREDNISOLONE OR OBSERVED WITHOUT THERAPY , 2002, Pediatric hematology and oncology.

[395]  M. Greaves.  Pathophysiology of Chronic Urticaria , 2002, International Archives of Allergy and Immunology.

[396]  J. Espinosa Zacarías,et al.  [Intravenous treatment with immunoglobulins in epileptic syndromes which are difficult to control]. , 2002, Revista de neurologia.

[397]  J. Piette,et al.  Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. , 2002, The Journal of rheumatology.

[398]  G. Fierlbeck,et al.  Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease. , 2002, Journal of the American Academy of Dermatology.

[399]  H. Schwartz,et al.  Intravenous gamma-globulin therapy in bronchial asthma. , 2002, Allergy and asthma proceedings.

[400]  A. Ohlsson,et al.  Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. , 2004, The Cochrane database of systematic reviews.

[401]  S. Vorstrup,et al.  Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. , 2001, Artificial organs.

[402]  A. Prieur,et al.  Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. , 2001, Rheumatology.

[403]  D. Kimpel,et al.  Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome. , 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[404]  C. Koski,et al.  Use of intravenous gamma globulins in neuroimmunologic diseases. , 2001, The Journal of allergy and clinical immunology.

[405]  K. Neftel,et al.  Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes , 2001, American journal of hematology.

[406]  A. Pardo,et al.  [A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia]. , 2001, Revista de neurologia.

[407]  G. Comi,et al.  Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy , 2001, Annals of neurology.

[408]  B. Mazer,et al.  Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin. , 2001, The Journal of allergy and clinical immunology.

[409]  S. Kumari,et al.  Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. , 2001, Clinical immunology.

[410]  A. Ghali,et al.  Post-transfusion purpura: case report , 2001, Annals of Hematology.

[411]  T. Small,et al.  A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation , 2001, Bone Marrow Transplantation.

[412]  N. Kelebek,et al.  Intravenous Immunoglobulin in Adult Varicella Pneumonia Complicated by Acute Respiratory Distress Syndrome , 2001, The Journal of international medical research.

[413]  A. Kaplan,et al.  Mechanisms of autoimmune activation of basophils in chronic urticaria. , 2001, The Journal of allergy and clinical immunology.

[414]  R. Holubkov,et al.  Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.

[415]  K. Werdan,et al.  Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. , 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[416]  H. Nagaraja,et al.  Welding-related parkinsonism: Clinical features, treatment, and pathophysiology , 2001, Neurology.

[417]  S. Spector,et al.  A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM , 2001, Neurology.

[418]  G. Avanzini,et al.  Positive response to immunomodulatory therapy in an adult patient with Rasmussen’s encephalitis , 2001, Neurology.

[419]  N. Wilson,et al.  Intravenous Immunoglobulin in Acute Rheumatic Fever: A Randomized Controlled Trial , 2001, Circulation.

[420]  G. Opelz,et al.  A RANDOMIZED AND PROSPECTIVE STUDY COMPARING TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN WITH MONOCLONAL ANTIBODIES FOR RESCUE OF KIDNEY GRAFTS WITH STEROID-RESISTANT REJECTION , 2001, Transplantation.

[421]  A. Tunkel,et al.  Treatment of potentially life-threatening enterovirus infections with pleconaril , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[422]  F. Ramisse,et al.  Effective Combination Therapy for Invasive Pneumococcal Pneumonia with Ampicillin and Intravenous Immunoglobulins in a Mouse Model , 2001, Antimicrobial Agents and Chemotherapy.

[423]  C. Kallenberg,et al.  The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. , 2001, Annals of internal medicine.

[424]  A. Lloyd,et al.  Kawasaki disease: is it caused by an infectious agent? , 2001, British journal of biomedical science.

[425]  V. Meininger,et al.  Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. , 2001, Brain : a journal of neurology.

[426]  E. Wang,et al.  Immunoglobulin for preventing respiratory syncytial virus infection. , 2006, The Cochrane database of systematic reviews.

[427]  S. Inaba,et al.  Post-transfusion thrombocytopenia in recipients with anti-HLA antibody. , 2000, Transfusion science.

[428]  P. Doorn,et al.  IVIg treatment improves multifocal motor neuropathy Easy to start but difficult to stop , 2000 .

[429]  K. Sandberg,et al.  Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. , 2000, The Journal of pediatrics.

[430]  J. Casanova,et al.  Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. , 2000, The Pediatric infectious disease journal.

[431]  R. Asero.  Are IVIG for chronic unremitting urticaria effective? , 2000, Allergy.

[432]  F. Bessho,et al.  A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. , 2000, International journal of hematology.

[433]  R. Montgomery,et al.  PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS , 2000, Transplantation.

[434]  N. Casadevall,et al.  Successful treatment of thymoma‐associated pure red cell aplasia with intravenous immunoglobulins , 2000, European journal of haematology.

[435]  F. Pomerri,et al.  Moderate-dose intravenous immunoglobulin treatment of Job's syndrome. Case report. , 2000, Minerva medica.

[436]  C. Alliot,et al.  Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: about two cases. , 2000, Therapie.

[437]  S. Jolles,et al.  The treatment of atopic dermatitis with adjunctive high‐dose intravenous immunoglobulin: a report of three patients and review of the literature , 2000, The British journal of dermatology.

[438]  M. Kuo,et al.  Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[439]  M. Kazatchkine,et al.  Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy , 2000, Ocular immunology and inflammation.

[440]  K. Katsouyanni,et al.  Prevention of infection in multiple trauma patients by high‐dose intravenous immunoglobulins , 2000, Critical care medicine.

[441]  F Alpay,et al.  High‐dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice , 1999, Acta paediatrica.

[442]  J. Perrot,et al.  [Solar urticaria: one case treated by intravenous immunoglobulin]. , 2000, Annales de dermatologie et de venereologie.

[443]  L. Dans,et al.  Intravenous immunoglobulin for treating sepsis and septic shock. , 2000, The Cochrane database of systematic reviews.

[444]  M. Tarantino.  Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children. , 2000, Seminars in hematology.

[445]  Y. El‐Sayed,et al.  A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. , 2000, American journal of obstetrics and gynecology.

[446]  A. Michon,et al.  High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. , 2000, Pediatric neurology.

[447]  J. Englund,et al.  Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin , 2000, Bone Marrow Transplantation.

[448]  R. Hirsch,et al.  Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience , 2000, Bone Marrow Transplantation.

[449]  Y. Shoenfeld,et al.  Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis , 2000, Rheumatology International.

[450]  W. Bossart,et al.  Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment , 1999, European Journal of Pediatrics.

[451]  J. Church,et al.  Effects of high-dose intravenous immunoglobulin on virus load in HIV-infected children. , 1999, Journal of acquired immune deficiency syndromes.

[452]  M. Floeter,et al.  The Stiff-Person Syndrome: An Autoimmune Disorder Affecting Neurotransmission of -Aminobutyric Acid , 1999, Annals of Internal Medicine.

[453]  M. Garvey,et al.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood , 1999, The Lancet.

[454]  T. Lerman-Sagie,et al.  Demyelinative Brainstem Encephalitis Responsive to Intravenous Immunoglobulin Therapy , 1999, Pediatrics.

[455]  C. Cunningham-Rundles,et al.  Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.

[456]  Y. Shoenfeld,et al.  Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin , 1999, International Archives of Allergy and Immunology.

[457]  P. Singhi,et al.  Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome. , 1999, Annals of tropical paediatrics.

[458]  J. Rosenbaum,et al.  The treatment of refractory uveitis with intravenous immunoglobulin. , 1999, American journal of ophthalmology.

[459]  A. Fischer,et al.  Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. , 1999, The Journal of pediatrics.

[460]  C. Teter,et al.  Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin—A report of eight patients , 1999, American journal of hematology.

[461]  R. Geha,et al.  Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. , 1999, The Journal of allergy and clinical immunology.

[462]  C. Cunningham-Rundles,et al.  A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. , 1999, Clinical immunology.

[463]  R. Kaul,et al.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[464]  E. Hollander,et al.  Brief Report: A Pilot Open Clinical Trial of Intravenous Immunoglobulin in Childhood Autism , 1999, Journal of autism and developmental disorders.

[465]  E. Gelfand,et al.  Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. , 1999, The Journal of allergy and clinical immunology.

[466]  J. Ulatowski,et al.  Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis , 1999, Neurology.

[467]  D. Quaglino,et al.  The immune system in the elderly , 1999, Immunologic research.

[468]  N. Gadoth,et al.  Intravenous immunoglobulin treatment in multiple sclerosis. , 1999, Neurology.

[469]  Smith Dw,et al.  Intrauterine anemia due to parvovirus B19: successful treatment with intravenous immunoglobulins. , 1999, Haematologica.

[470]  J. Newburger,et al.  Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. , 1998, The Pediatric infectious disease journal.

[471]  E. Gelfand,et al.  Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma. , 1998, Chest.

[472]  Wollina,et al.  Disabling morphoea of childhood—beneficial effect of intravenous immunoglobulin therapy , 1998, Clinical and experimental dermatology.

[473]  J. Pouchot,et al.  Acquired hemophilia due to factor VIII inhibitors in 34 patients. , 1998, The American journal of medicine.

[474]  M. Fishbein,et al.  Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. , 1998, Transplantation.

[475]  Q. Hamid,et al.  Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. , 1998, The Journal of allergy and clinical immunology.

[476]  David B. Speights,et al.  High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[477]  B. Gerritsen,et al.  Immunoglobulin replacement treatment by rapid subcutaneous infusion , 1998, Archives of disease in childhood.

[478]  K. Sullivan,et al.  Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. , 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[479]  C. V. Jensen,et al.  Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis , 1998, Neurology.

[480]  L. Hammarström,et al.  Induction of unresponsiveness against IgA in IgA‐deficient patients on subcutaneous immunoglobulin infusion therapy , 1998, Clinical and experimental immunology.

[481]  J. Piette,et al.  Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. , 1998, Clinical and experimental rheumatology.

[482]  A. Wense,et al.  Intrathekale Interferontherapie einer chronischen Echovirusmeningoenzephalitis bei Agammaglobulinämie vom Typ Bruton , 1998 .

[483]  H. Einsele,et al.  Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT) , 1998, Bone Marrow Transplantation.

[484]  A. Plioplys,et al.  Intravenous Immunoglobulin Treatment of Children With Autism , 1998, Journal of child neurology.

[485]  B. Niggemann,et al.  Prospective, double‐blind, placebo‐controlled, multicentre study on the effect of high‐dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[486]  A. Achiron,et al.  Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses , 1998, Neurology.

[487]  B. Pollock,et al.  The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. , 1998, Seminars in perinatology.

[488]  Winkelmann,et al.  Intravenous immunoglobulin in autoimmune chronic urticaria , 1998, The British journal of dermatology.

[489]  A. Knutsen,et al.  NATURAL HISTORY OF SELECTIVE ANTIBODY DEFICIENCY TO BACTERIAL POLYSACCHARIDE ANTIGENS IN CHILDREN , 1998 .

[490]  R. Korinthenberg.  Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. , 1998, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[491]  A. von der Wense,et al.  [Intrathecal interferon therapy in chronic echovirus meningoencephalitis in Bruton type agammaglobulinemia]. , 1998, Klinische Padiatrie.

[492]  K. Welte,et al.  Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. , 1998, Blood.

[493]  H. Hartung,et al.  Side effects of high-dose intravenous immunoglobulins. , 1997, Clinical neuropharmacology.

[494]  C. Pothoulakis,et al.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis , 1997, Gut.

[495]  Y. Sultan.  Acquired hemophilia and its treatment. , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[496]  A. Fischer,et al.  Clinical spectrum of X-linked hyper-IgM syndrome. , 1997, The Journal of pediatrics.

[497]  I. Hickie,et al.  Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. , 1997, The American journal of medicine.

[498]  C. Chastang,et al.  A randomised clinical trial comparing interferon-α and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM , 1997 .

[499]  S. Chevret,et al.  Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis , 1997 .

[500]  S. Muchnik,et al.  Long‐term follow‐up of Lambert‐Eaton syndrome treated with intravenous immunoglobulin , 1997, Muscle & nerve.

[501]  Y. Shoenfeld,et al.  Successful treatment of early secondary myelofibrosis in SLE with IVIG , 1997, Lupus.

[502]  M. Rich,et al.  Treatment of Lambert‐Eaton syndrome with intravenous immunoglobulin , 1997, Muscle & nerve.

[503]  C. V. Jensen,et al.  A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: Preliminary results , 1997, Multiple sclerosis.

[504]  J. Dambrosia,et al.  Treatment of inclusion-body myositis with IVIg , 1997, Neurology.

[505]  G. Nahler,et al.  Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis , 1997, The Lancet.

[506]  W. Hacke,et al.  Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome , 1997 .

[507]  P. Vespa,et al.  Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. , 1997, The American journal of medicine.

[508]  G. Nahler,et al.  Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group. , 1997, Lancet.

[509]  C. Chastang,et al.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[510]  P. Schwandt,et al.  Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin‐dependent diabetes mellitus , 1997, Journal of clinical apheresis.

[511]  T. Abrahamsen,et al.  Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. , 1996, Pediatrics.

[512]  M. Passo,et al.  Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. , 1996, The Journal of pediatrics.

[513]  J. Dambrosia,et al.  A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy , 1996, Annals of neurology.

[514]  G. Hommel,et al.  Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy , 1996, Clinical and experimental immunology.

[515]  J. Litzman,et al.  Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. , 1996, Archives of disease in childhood.

[516]  P. Bain,et al.  Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome , 1996, Neurology.

[517]  Sudhir Gupta,et al.  Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics , 1996, Journal of autism and developmental disorders.

[518]  R. Champlin,et al.  Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high‐dose intravenous immunoglobulin , 1996, American journal of hematology.

[519]  C. Bolton,et al.  Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. , 1996, Brain : a journal of neurology.

[520]  Y. Naparstek,et al.  Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[521]  R. Schneider,et al.  Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study. , 1996, The Journal of rheumatology.

[522]  Prieur Am.  Intravenous immunoglobulins in Still's disease: still controversial, still unproven. , 1996 .

[523]  F. Dammacco,et al.  Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti‐DNA‐reactive IgG , 1996, Clinical and experimental immunology.

[524]  E. Heinze.  Immunoglobulins in children with autoimmune diabetes mellitus. , 1996, Clinical and experimental rheumatology.

[525]  K. Werdan,et al.  Supplemental immune globulins in sepsis: a critical appraisal , 1996, Clinical and experimental immunology.

[526]  D. Wakefield,et al.  Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. , 1996, Clinical and experimental rheumatology.

[527]  R. Sundel,et al.  Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. , 1996, The Journal of rheumatology.

[528]  H. Deeg,et al.  A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[529]  G. Schiffman,et al.  Impaired Antibody Responses to Pneumococcal Polysaccharide in Elderly Patients with Low Serum Vitamin B12 Levels , 1996, Annals of Internal Medicine.

[530]  V. Bril,et al.  Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome , 1996, Neurology.

[531]  C. Brun-Buisson,et al.  Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin. , 1996, Scandinavian journal of rheumatology.

[532]  K. Durongpisitkul,et al.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. , 1995, Pediatrics.

[533]  J. Kinet,et al.  Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? , 1995, The Journal of clinical investigation.

[534]  Michele D. Kleiman,et al.  Acute Disseminated Encephalomyelitis: Response to Intravenous Immunoglobulin? , 1995, Journal of child neurology.

[535]  J. Bussel,et al.  Evans Syndrome: Results of a Pilot Study Utilizing a Multiagent Treatment Protocol , 1995, Journal of pediatric hematology/oncology.

[536]  W. Lynn,et al.  Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. , 1995, Thorax.

[537]  L. H. van den Berg,et al.  Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[538]  C. Verfaillie,et al.  Posttransfusion purpura following bone marrow transplantation , 1995, Transfusion.

[539]  F. Ovalı,et al.  High-Dose Intravenous Immunoglobulin Therapy for Rhesus Haemolytic Disease , 1995, The Journal of international medical research.

[540]  M. Dalakas.  Immunopathogenesis of inflammatory myopathies , 1995, Annals of neurology.

[541]  J. V. D. Meer,et al.  Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies , 1995, The Lancet.

[542]  P. Musto,et al.  PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUN0GLOBULINS IN MULTIPLE MYELOMA , 1995, British journal of haematology.

[543]  L. Hammarström,et al.  Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs , 1995, The Lancet.

[544]  V. Dubowitz,et al.  Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases. , 1995, Archives of disease in childhood.

[545]  J. Englund,et al.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. , 1995, Bone marrow transplantation.

[546]  W. Litchy,et al.  A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy , 1994, Annals of neurology.

[547]  K. Sullivan,et al.  A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.

[548]  R. Gelber,et al.  A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. , 1994, The New England journal of medicine.

[549]  A. Saven,et al.  Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia. , 1994, American journal of clinical pathology.

[550]  E. Kanfer,et al.  Severe rotavirus-associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. , 1994, Bone marrow transplantation.

[551]  H. Wieser,et al.  Treatment of refractory epilepsy with intravenous immunoglobulins , 1994, International journal of clinical & laboratory research.

[552]  H. Chapel,et al.  The use of intravenous immune globulin in multiple myeloma. , 1994, Clinical and experimental immunology.

[553]  B. Björkstén,et al.  Slight steroid‐sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma , 1994, Allergy.

[554]  L. Mofenson,et al.  Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus‐infected children , 1994, The Pediatric infectious disease journal.

[555]  D. Fish,et al.  Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy) , 1994, Neurology.

[556]  B. Wechsler,et al.  Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. , 1994, The Journal of rheumatology.

[557]  H. Chapel,et al.  Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma , 1994, The Lancet.

[558]  H. Kimata.  High dose gammaglobulin treatment for atopic dermatitis. , 1994, Archives of disease in childhood.

[559]  O. Blin,et al.  Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies , 1994, Neurology.

[560]  M. Rudnick,et al.  Acute renal failure after intravenous immunoglobulin therapy. , 1994, The Journal of rheumatology.

[561]  G. Polito,et al.  27. ORAL IMMUNOGLOBULINS FOR TREATMENT OF ACUTE ROTAVIRAL GASTROENTERITIS , 1993, Journal of Pediatric Gastroenterology and Nutrition.

[562]  R. Hughes.  The spectrum of acquired demyelinating polyradiculoneuropathy. , 1994, Acta neurologica Belgica.

[563]  M. Thomas,et al.  Rapid subcutaneous immunoglobulin infusions in children , 1993, The Lancet.

[564]  C. Cunningham-Rundles,et al.  Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients , 1993, American journal of hematology.

[565]  F. Rodeghiero,et al.  Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. , 1993, Haematologica.

[566]  Y. Shoenfeld,et al.  The Effect of Intravenous γ-Globulin on the Induction of Experimental Antiphospholipid Syndrome , 1993 .

[567]  R. Shalev,et al.  Intravenous high‐dose gammaglobulins for intractable childhood epilepsy , 1993, Acta neurologica Scandinavica.

[568]  T. Klumpp,et al.  Autoimmune neutropenia after bone marrow transplantation [letter; comment] , 1993 .

[569]  R. Geha,et al.  Therapy for patients with recurrent infections and low serum IgG3 levels. , 1993, The Journal of allergy and clinical immunology.

[570]  J. Herman,et al.  Autoimmune neutropenia after bone marrow transplantation. , 1993, Blood.

[571]  R. Collins,et al.  High-Dose Weekly Intravenous Immunoglobulin to Prevent Infections in Patients Undergoing Autologous Bone Marrow Transplantation or Severe Myelosuppressive Therapy: A Study of the American Bone Marrow Transplant Group , 1993, Annals of Internal Medicine.

[572]  A N N Gardulf,et al.  The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions , 1993, Clinical and experimental immunology.

[573]  L. Hammarström,et al.  Oral immunoglobulin treatment in Campylobacter jejuni enteritis , 1993, The Lancet.

[574]  D. Jayne,et al.  ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. , 1993, Journal of autoimmunity.

[575]  A. Ventura,et al.  Anti‐Rh(D) immunoglobulin for autoimmune neutropenia of infancy , 1993, Acta paediatrica.

[576]  Y. Shoenfeld,et al.  The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. , 1993, Clinical immunology and immunopathology.

[577]  N. M. Whear,et al.  Necrotising fasciitis. , 1993, British journal of plastic surgery.

[578]  L. Hammarström,et al.  Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency. , 1993, Immunodeficiency.

[579]  J. Herman,et al.  Autoimmune neutropenia following peripheral blood stem cell transplantation , 1992, American journal of hematology.

[580]  G. Rinaldi,et al.  High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[581]  V. Blanchette,et al.  Role of intravenous immunoglobulin G in autoimmune hematologic disorders. , 1992, Seminars in hematology.

[582]  V. Wahn,et al.  High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. , 1992, The Journal of pediatrics.

[583]  S. Donta,et al.  Intravenous immunoglobulin therapy for toxic shock syndrome. , 1992, JAMA.

[584]  D. Ikle,et al.  Hypogammaglobulinemia in asthmatic patients. , 1992, Annals of allergy.

[585]  P. Schmitz,et al.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.

[586]  H. Tilg,et al.  Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[587]  J. Liese,et al.  High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. , 1992, American journal of diseases of children.

[588]  A. Winkelstein,et al.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma. , 1992, Clinical reviews in allergy.

[589]  J. Rubo.  High-dose immune globulin therapy for hyperbilirubinemia-caused by Rh hemolytic disease , 1992 .

[590]  R. Moss.  Association of isolated IgG4 deficiency with recurrent respiratory tract infection , 1992 .

[591]  R. Moss,et al.  Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection. , 1992, The Journal of pediatrics.

[592]  C. Mueller-Eckhardt,et al.  [Clinical and serologic studies in 34 patients with post-transfusion purpura]. , 1992, Beitrage zur Infusionstherapie = Contributions to infusion therapy.

[593]  G. Mariani,et al.  Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis. , 1992, Clinical and experimental rheumatology.

[594]  J. Vivant,et al.  [Intravenous immunoglobulins in Guillain-Barré syndrome]. , 1992, Annales francaises d'anesthesie et de reanimation.

[595]  P. Schmitz,et al.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.

[596]  I. Jajić.  Epidemiology of hypertrophic osteoarthropathy. , 1992, Clinical and experimental rheumatology.

[597]  H. Ochs,et al.  Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis. , 1992, The American journal of gastroenterology.

[598]  T. Barbui,et al.  In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti‐idiotypic mechanism , 1991, American journal of hematology.

[599]  M. Ballow.  Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases , 1991, Cancer.

[600]  A. Griffiths,et al.  Benefit of oral immune globulin therapy in patients with immunodeficiency and chronic diarrhea. , 1991, The Journal of pediatrics.

[601]  A. Rubino,et al.  Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. , 1991, The Pediatric infectious disease journal.

[602]  Stiehm Er.  New Uses for Intravenous Immune Globulin , 1991 .

[603]  L. Mofenson,et al.  Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[604]  M. Weinstein,et al.  Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. , 1991, The New England journal of medicine.

[605]  R. Buckley,et al.  The use of intravenous immune globulin in immunodeficiency diseases. , 1991, The New England journal of medicine.

[606]  M Takahashi,et al.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. , 1991, The New England journal of medicine.

[607]  E. Gelfand,et al.  An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. , 1991, The Journal of allergy and clinical immunology.

[608]  C. Pothoulakis,et al.  Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. , 1991, The Journal of pediatrics.

[609]  H. Hill,et al.  Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. , 1991, The Journal of pediatrics.

[610]  K. Sheerin,et al.  Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. , 1991, The Journal of allergy and clinical immunology.

[611]  H. Levison,et al.  Advanced lung disease in a patient with cystic fibrosis and hypogammaglobulinemia: response to intravenous immune globulin therapy. , 1990, The Journal of pediatrics.

[612]  K. Sullivan,et al.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.

[613]  C. Heilmann,et al.  Intravenous Immunoglobulin: A Single-Blind Trial in Children with Lennox-Gastaut Syndrome , 1990, Neuropediatrics.

[614]  J. Bussel.  Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial. , 1990, Reviews of infectious diseases.

[615]  R. Wasserman,et al.  Persistent enterovirus infection in culture-negative meningoencephalitis: demonstration by enzymatic RNA amplification. , 1990, The Journal of infectious diseases.

[616]  J. Meulstee,et al.  High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy , 1990, Neurology.

[617]  D. M. Temple,et al.  Intravenous Gamma Globulin as Adjunct Therapy for Severe Group B Streptococcal Disease in the Newborn , 1990, American journal of perinatology.

[618]  Heiner Dc,et al.  Quantitative immunoglobulins and IgG subclasses in patients with corticosteroid-dependent reversible airway obstruction. , 1989 .

[619]  A. Parke,et al.  The uses of intravenous immune globulin in collagen vascular disorders. , 1989, The Journal of allergy and clinical immunology.

[620]  P. Helin,et al.  A preliminary trial of high-dose intravenous immunoglobulin to a patient with euthyroid ophthalmopathy. , 1989, Thyroidology.

[621]  C. Anasetti,et al.  Graft-v-host disease is associated with autoimmune-like thrombocytopenia. , 1989, Blood.

[622]  R. Cowan,et al.  Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis. , 1989, The Journal of pediatrics.

[623]  H. Möllmann,et al.  IgG-2 deficiency in asthmatic patients course of disease in four adults. , 1989, Agents and actions. Supplements.

[624]  J. Schoettler,et al.  Quantitative immunoglobulins and IgG subclasses in patients with corticosteroid-dependent reversible airway obstruction. , 1989, Annals of allergy.

[625]  D. Vergani,et al.  IgG subclass deficiency in asthma , 1988, Archives of disease in childhood.

[626]  E. Reed,et al.  Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. , 1988, Annals of internal medicine.

[627]  D. Stover,et al.  Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. , 1988, Annals of internal medicine.

[628]  A. Randomized.  Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. , 1988 .

[629]  R. Geha,et al.  Impaired antibody responses in the hyperimmunoglobulin E syndrome. , 1988, The Journal of allergy and clinical immunology.

[630]  U. Bengtsson,et al.  Immunoglobulin subclass deficiency , 1988, The Pediatric infectious disease journal.

[631]  J. Dwyer,et al.  Intraventricular gamma‐globulin for the management of enterovirus encephalitis , 1988, The Pediatric infectious disease journal.

[632]  E. Besa.  Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. , 1988, The American journal of medicine.

[633]  F. Savéry.  Intravenous immunoglobulin treatment of rheumatoid arthritis-associated immunodeficiency. , 1988, Clinical therapeutics.

[634]  L. Caliguiri,et al.  Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy. , 1988, The Journal of pediatrics.

[635]  J. Bussel,et al.  Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. , 1987, The American journal of medicine.

[636]  J. Kurtzberg,et al.  Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias. , 1987, The American journal of medicine.

[637]  K. Sullivan.  Immunoglobulin therapy in bone marrow transplantation. , 1987, The American journal of medicine.

[638]  G. Massey,et al.  Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia. , 1987, The Journal of pediatrics.

[639]  Henry Levison,et al.  HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASE , 1987, The Lancet.

[640]  M. Eibl,et al.  Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment. , 1987, Clinical immunology and immunopathology.

[641]  M. Leahy.  SUBCUTANEOUS IMMUNOGLOBULIN HOME TREATMENT IN HYPOGAMMAGLOBULINAEMIA , 1986, The Lancet.

[642]  A. Burks,et al.  Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. , 1986, The New England journal of medicine.

[643]  A. Sjöholm,et al.  IgG3 deficiency: common in obstructive lung disease. Hereditary in families with immunodeficiency and autoimmune disease. , 1986, Monographs in allergy.

[644]  R. Yolken,et al.  Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis. , 1985, The Journal of clinical investigation.

[645]  H. Ochs,et al.  Echovirus encephalitis/myositis in X-linked agammaglobulinemia. , 1985, The New England journal of medicine.

[646]  H. Levison,et al.  Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. , 1985, The American journal of medicine.

[647]  F. Breedveld,et al.  High dose intravenous gamma globulin for Felty's syndrome. , 1985, The Journal of rheumatology.

[648]  J. Winkelstein,et al.  X‐Linked Agammaglobulinemia: An Analysis of 96 Patients , 1985, Medicine.

[649]  J. Dwyer,et al.  Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin. , 1985, The New England journal of medicine.

[650]  M. Kazatchkine,et al.  ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN , 1984, The Lancet.

[651]  C. Cunningham-Rundles,et al.  Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. , 1984, Annals of internal medicine.

[652]  J. Bussel,et al.  Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. , 1983, Blood.

[653]  A. Fauci,et al.  High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. , 1982, JAMA.

[654]  J. Clot,et al.  Immunomodulating effect of human placenta-eluted gamma globulins in rheumatoid arthritis. , 1982, Arthritis and rheumatism.

[655]  H. Ochs,et al.  Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. , 1982, Clinical immunology and immunopathology.

[656]  H. Ochs,et al.  Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. , 1981, The New England journal of medicine.

[657]  A. Fauci,et al.  Immunoglobulin replacement therapy by slow subcutaneous infusion. , 1980, Annals of internal medicine.

[658]  L. Harker,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .

[659]  R. Geha,et al.  Hypogammaglobulinemia in patients with cystic fibrosis. , 1980, The New England journal of medicine.

[660]  B. Golding,et al.  Intravenous immunoglobulin therapy for antibody deficiency. , 1979, Clinical and experimental immunology.

[661]  G. Morley.  ASBESTOS IN THE AIR , 1976, The Lancet.

[662]  D. Danks,et al.  Letter: Anticonvulsants and congenital abnormalities. , 1974, Lancet.